# HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/her2-low-status-as-a-distinct-breast-cancer-subtype-myth-or-truth-analysis-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | G Schmidt,Oleg Gluz,Matthias Christgen,Mattea Reinisch,Sherko Kümmel,Ulrike Nitz,Michael Braun,Bahriye Aktas,Kerstin Lüdtke-Heckenkamp,Helmut Forstbauer,Eva‐Maria Grischke,Claudia Schumacher,Rolf Mahlberg,Wolfram Malter,Toralf Reimer,Benno Nuding,Andrea Stefek,Rachel Wuerstlein,Monika Graeser,Katarzyna Jóźwiak,Sandy Burmeister,Christine zu Eulenburg,Michael Lauseker,Cornelia Kolberg‐Liedtke,Aleix Prat,Peter Schmid,Frederick L. Baehner,Hans Kreipe,Erich-Franz Solomayer,Nadia Harbeck,on behalf of the West German Stud y Group investigators |
| Citations | 8 |
| DOI | 10.1186/s13058-025-01969-z |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/s13058-025-01969-z |
| OpenAlex ID | https://openalex.org/W4407559602 |
| PMID | 39953511 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Erich-Franz Solomayer](https://scholariq.org/researchers/erich-franz-solomayer/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.